Human Fc receptor-like 5 binds intact IgG via mechanisms distinct from those of Fc receptors

Journal of Immunology

Volumn 190, Issue 11, 2013, Pages 5739-5746

  Franco, Andrea ^a   Damdinsuren, Bazarragchaa ^a   Ise, Tomoko ^b   Dement Brown, Jessica ^a   Li, Huifang ^a   Nagata, Satoshi ^b   Tolnay, Mate ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b SANFORD RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; FC RECEPTOR; FC RECEPTOR LIKE 5; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; SIALIC ACID; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; BINDING KINETICS; CELL SURFACE; CONTROLLED STUDY; ENZYME REGULATION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN AGGREGATE; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; SURFACE PLASMON RESONANCE;

ANTIBODY AFFINITY; CELL LINE; CELL MEMBRANE; EPITOPES; HUMANS; IMMUNOGLOBULIN G; KINETICS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECEPTORS, CELL SURFACE; RECEPTORS, FC; RECOMBINANT PROTEINS;

EID: 84878097614     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202860     Document Type: Article

References (45)

1. Davis, R. S., Y. H. Wang, H. Kubagawa, and M. D. Cooper. 2001. Identification of a family of Fc receptor homologs with preferential B cell expression. Proc. Natl. Acad. Sci. USA 98: 9772-9777. (Pubitemid 32769379)
2. Hatzivassiliou, G., I. Miller, J. Takizawa, N. Palanisamy, P. H. Rao, S. Iida, S. Tagawa, M. Taniwaki, J. Russo, A. Neri, et al. 2001. IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity 14: 277-289. (Pubitemid 32289292)
3. Xu, M. J., R. Zhao, H. Cao, and Z. J. Zhao. 2002. SPAP2, an Ig family receptor containing both ITIMs and ITAMs. Biochem. Biophys. Res. Commun. 293: 1037-1046. (Pubitemid 34694146)
4. Davis, R. S. 2007. Fc receptor-like molecules. Annu. Rev. Immunol. 25: 525-560. (Pubitemid 46697916)
5. Leu, C. M., R. S. Davis, L. A. Gartland, W. D. Fine, and M. D. Cooper. 2005. FcRH1: an activation coreceptor on human B cells. Blood 105: 1121-1126.
6. Ehrhardt, G. R., R. S. Davis, J. T. Hsu, C. M. Leu, A. Ehrhardt, and M. D. Cooper. 2003. The inhibitory potential of Fc receptor homolog 4 on memory B cells. Proc. Natl. Acad. Sci. USA 100: 13489-13494. (Pubitemid 37444769)
7. Haga, C. L., G. R. Ehrhardt, R. J. Boohaker, R. S. Davis, and M. D. Cooper. 2007. Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment. Proc. Natl. Acad. Sci. USA 104: 9770-9775. (Pubitemid 47175342)
8. Kochi, Y., K. Myouzen, R. Yamada, A. Suzuki, T. Kurosaki, Y. Nakamura, and K. Yamamoto. 2009. FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling. J. Immunol. 183: 5502-5510.
9. Jackson, T. A., C. L. Haga, G. R. Ehrhardt, R. S. Davis, and M. D. Cooper. 2010. FcR-like 2 inhibition of B cell receptor-mediated activation of B cells. J. Immunol. 185: 7405-7412.
10. Dement-Brown, J., C. S. Newton, T. Ise, B. Damdinsuren, S. Nagata, and M. Tolnay. 2012. Fc receptor-like 5 promotes B cell proliferation and drives the development of cells displaying switched isotypes. J. Leukoc. Biol. 91: 59-67.
11. Polson, A. G., B. Zheng, K. Elkins, W. Chang, C. Du, P. Dowd, L. Yen, C. Tan, J. A. Hongo, H. Koeppen, and A. Ebens. 2006. Expression pattern of the human FcRH/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemia. Int. Immunol. 18: 1363-1373. (Pubitemid 44446830)
12. Mohan, J., J. Dement-Brown, S. Maier, T. Ise, B. Kempkes, and M. Tolnay. 2006. Epstein-Barr virus nuclear antigen 2 induces FcRH5 expression through CBF1. Blood 107: 4433-4439. (Pubitemid 43801370)
13. Kochi, Y., R. Yamada, A. Suzuki, J. B. Harley, S. Shirasawa, T. Sawada, S. C. Bae, S. Tokuhiro, X. Chang, A. Sekine, et al. 2005. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat. Genet. 37: 478-485. (Pubitemid 40617275)
14. Li, F. J., S. Ding, J. Pan, M. A. Shakhmatov, E. Kashentseva, J. Wu, Y. Li, S. J. Soong, N. Chiorazzi, and R. S. Davis. 2008. FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia. Blood 112: 179-187.
15. Ise, T., H. Maeda, K. Santora, L. Xiang, R. J. Kreitman, I. Pastan, and S. Nagata. 2005. Immunoglobulin superfamily receptor translocation associated 2 protein on lymphoma cell lines and hairy cell leukemia cells detected by novel monoclonal antibodies. Clin. Cancer Res. 11: 87-96. (Pubitemid 40075782)
16. Ise, T., S. Nagata, R. J. Kreitman, W. H. Wilson, A. S. Wayne, M. Stetler-Stevenson, M. R. Bishop, D. A. Scheinberg, L. Rassenti, T. J. Kipps, et al. 2007. Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma. Leukemia 21: 169-174. (Pubitemid 44921849)
17. Owczarczyk, K., P. Lal, A. R. Abbas, K. Wolslegel, C. T. Holweg, W. Dummer, A. Kelman, P. Brunetta, N. Lewin-Koh, M. Sorani, et al. 2011. A plasmablast biomarker for nonresponse to antibody therapy to CD20 in rheumatoid arthritis. Sci. Transl. Med. 3: 101ra92.
18. Elkins, K., B. Zheng, M. Go, D. Slaga, C. Du, S. J. Scales, S. F. Yu, J. McBride, R. de Tute, A. Rawstron, et al. 2012. FcRL5 as a target of antibody-drug conjugates for the treatment of multiple myeloma. Mol. Cancer Ther. 11: 2222-2232.
19. Schreeder, D. M., J. P. Cannon, J. Wu, R. Li, M. A. Shakhmatov, and R. S. Davis. 2010. Cutting edge: FcR-like 6 is an MHC class II receptor. J. Immunol. 185: 23-27.
20. Wilson, T. J., S. Gilfillan, and M. Colonna. 2010. Fc receptor-like A associates with intracellular IgG and IgM but is dispensable for antigen-specific immune responses. J. Immunol. 185: 2960-2967.
21. Santiago, T., S. V. Kulemzin, E. S. Reshetnikova, N. A. Chikaev, O. Y. Volkova, L. V. Mechetina, M. Zhao, R. S. Davis, A. V. Taranin, A. M. Najakshin, et al. 2011. FCRLA is a resident endoplasmic reticulum protein that associates with intracellular Igs, IgM, IgG and IgA. Int. Immunol. 23: 43-53.
22. Wilson, T. J., A. Fuchs, and M. Colonna. 2012. Cutting edge: human FcRL4 and FcRL5 are receptors for IgA and IgG. J. Immunol. 188: 4741-4745.
23. Nimmerjahn, F., and J. V. Ravetch. 2008. Fcγ receptors as regulators of immune responses. Nat. Rev. Immunol. 8: 34-47.
24. Hambly, D. M., D. D. Banks, J. L. Scavezze, C. C. Siska, and H. S. Gadgil. 2009. Detection and quantitation of IgG 1 hinge aspartate isomerization: a rapid degradation in stressed stability studies. Anal. Chem. 81: 7454-7459.
25. Kaneko, Y., F. Nimmerjahn, and J. V. Ravetch. 2006. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313: 670-673. (Pubitemid 44201145)
26. Stevenson, G. T., and K. J. Dorrington. 1970. The recombination of dimers of immunoglobulin peptide chains. Biochem. J. 118: 703-712.
27. Nagata, S., G. Salvatore, and I. Pastan. 2003. DNA immunization followed by a single boost with cells: a protein-free immunization protocol for production of monoclonal antibodies against the native form of membrane proteins. J. Immunol. Methods 280: 59-72. (Pubitemid 37289216)
28. Vidal-Laliena, M., X. Romero, S. March, V. Requena, J. Petriz, and P. Engel. 2005. Characterization of antibodies submitted to the B cell section of the 8th Human Leukocyte Differentiation Antigens Workshop by flow cytometry and immunohistochemistry. Cell. Immunol. 236: 6-16. (Pubitemid 41771079)
29. Friguet, B., A. F. Chaffotte, L. Djavadi-Ohaniance, and M. E. Goldberg. 1985. Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J. Immunol. Methods 77: 305-319. (Pubitemid 15103678)
30. Ise, T., R. J. Kreitman, I. Pastan, and S. Nagata. 2006. Sandwich ELISAs for soluble immunoglobulin superfamily receptor translocation-associated 2 (IRTA2)/FcRH5 (CD307) proteins in human sera. Clin. Chem. Lab. Med. 44: 594-602. (Pubitemid 43735632)
31. Nagata, S., Y. Numata, M. Onda, T. Ise, Y. Hahn, B. Lee, and I. Pastan. 2004. Rapid grouping of monoclonal antibodies based on their topographical epitopes by a label-free competitive immunoassay. J. Immunol. Methods 292: 141-155. (Pubitemid 39179870)
32. Maenaka, K., P. A. van der Merwe, D. I. Stuart, E. Y. Jones, and P. Sondermann. 2001. The human low affinity Fcγ receptors IIa, IIb, and III bind IgG with fast kinetics and distinct thermodynamic properties. J. Biol. Chem. 276: 44898-44904.
33. Bruhns, P., B. Iannascoli, P. England, D. A. Mancardi, N. Fernandez, S. Jorieux, and M. Daëron. 2009. Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses. Blood 113: 3716-3725.
34. Ferrara, C., F. Stuart, P. Sondermann, P. Brünker, and P. Umaña. 2006. The carbohydrate at FcγRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms. J. Biol. Chem. 281: 5032-5036. (Pubitemid 43847767)
35. Mimura, Y., P. Sondermann, R. Ghirlando, J. Lund, S. P. Young, M. Goodall, and R. Jefferis. 2001. Role of oligosaccharide residues of IgG1-Fc in FcγRIIb binding. J. Biol. Chem. 276: 45539-45547.
36. Stadlmann, J., A. Weber, M. Pabst, H. Anderle, R. Kunert, H. J. Ehrlich, H. Peter Schwarz, and F. Altmann. 2009. A close look at human IgG sialylation and subclass distribution after lectin fractionation. Proteomics 9: 4143-4153.
37. Guhr, T., J. Bloem, N. I. Derksen, M. Wuhrer, A. H. Koenderman, R. C. Aalberse, and T. Rispens. 2011. Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia. PLoS ONE 6: e21246.
38. Käsermann, F., D. J. Boerema, M. Rüegsegger, A. Hofmann, S. Wymann, A. W. Zuercher, and S. Miescher. 2012. Analysis and functional consequences of increased Fab-sialylation of intravenous immunoglobulin (IVIG) after lectin fractionation. PLoS ONE 7: e37243.
39. Mimura, Y., S. Church, R. Ghirlando, P. R. Ashton, S. Dong, M. Goodall, J. Lund, and R. Jefferis. 2000. The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms. Mol. Immunol. 37: 697-706. (Pubitemid 32244118)
40. Sondermann, P., R. Huber, V. Oosthuizen, and U. Jacob. 2000. The 3.2-A crystal structure of the human IgG1 Fc fragment-FcγRIII complex. Nature 406: 267-273. (Pubitemid 30604397)
41. Wypych, J., M. Li, A. Guo, Z. Zhang, T. Martinez, M. J. Allen, S. Fodor, D. N. Kelner, G. C. Flynn, Y. D. Liu, et al. 2008. Human IgG2 antibodies display disulfide-mediated structural isoforms. J. Biol. Chem. 283: 16194-16205.
42. Liu, Y. D., X. Chen, J. Z. Enk, M. Plant, T. M. Dillon, and G. C. Flynn. 2008. Human IgG2 antibody disulfide rearrangement in vivo. J. Biol. Chem. 283: 29266-29272.
43. Yoo, E. M., L. A. Wims, L. A. Chan, and S. L. Morrison. 2003. Human IgG2 can form covalent dimers. J. Immunol. 170: 3134-3138. (Pubitemid 36302189)
44. van der Neut Kolfschoten, M., J. Schuurman, M. Losen, W. K. Bleeker, P. Martínez-Martínez, E. Vermeulen, T. H. den Bleker, L. Wiegman, T. Vink, L. A. Aarden, et al. 2007. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 317: 1554-1557. (Pubitemid 47417435)
45. Saphire, E. O., R. L. Stanfield, M. D. Crispin, P. W. Parren, P. M. Rudd, R. A. Dwek, D. R. Burton, and I. A. Wilson. 2002. Contrasting IgG structures reveal extreme asymmetry and flexibility. J. Mol. Biol. 319: 9-18. (Pubitemid 34729482)